Table 2.
Risk factor | Studies (n) |
Category | Subjects (n) |
Number with 30-day hospital readmission | Pooled OR (95% CI) |
Demographics | |||||
Gender | 16 | Female | 1 131 305 | 148 167 | 0.94 (0.91 to 0.97) |
Male | 1 032 472 | 156 109 | |||
Age | 8 | ≥65 | 887 353 | 122 710 | 1.23 (1.08 to 1.40) |
<65 | 608 471 | 78 647 | |||
Race | 14 | White | 1 452 006 | 198 337 | 0.89 (0.84 to 0.94) |
Non-White | 663 475 | 99 747 | |||
Insurance type | 7 | Medicare and Medicaid | 589 376 | 97 976 | 1.41 (1.22 to 1.63) |
Private insurance | 221 078 | 29 042 | |||
Comorbidities | |||||
Heart failure | 4 | Yes | 9173 | 2052 | 1.81 (1.67 to 1.96) |
No | 33 283 | 4941 | |||
Respiratory disease | 8 | Yes | 135 281 | 24 203 | 1.33 (1.31 to 1.36) |
No | 468 257 | 66 317 | |||
Depression | 6 | Yes | 62 871 | 10 524 | 1.32 (1.20 to 1.45) |
No | 441 233 | 51 700 | |||
Renal disease | 4 | Yes | 84 595 | 16 671 | 1.69 (1.34 to 2.12) |
No | 330 966 | 44 477 | |||
Hypertension | 6 | Yes | 194 365 | 30 292 | 1.01 (0.98 to 1.03) |
No | 114 349 | 15 172 | |||
Diabetes-related medication | |||||
Insulin therapy | 5 | Yes | 272 420 | 38 440 | 1.45 (1.24 to 1.71) |
No | 637 554 | 70 684 | |||
Inpatient factor | |||||
Length of stay (days) | 3 | 1 996 909 | 1.06 (1.01 to 1.12) |